Log In
Print
BCIQ
Print
Print this Print this
 

BM32

  Manage Alerts
Collapse Summary General Information
Company Biomay AG
DescriptionRecombinant peptide-carrier fusion protein vaccine against grass pollen allergens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat grass pollen allergy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today